CRISPR-Cas Technology, the Tool of the Future

Alejandro Esquivel Álvarez, Elías Quesada Morales, María Paz Villegas Calero, Daniela Matarrita Brenes, M. F. Rojas Salas, German Madrigal Redondo, Marianela Chavarría Rojas, Eleaneth Baltodano Viales
{"title":"CRISPR-Cas Technology, the Tool of the Future","authors":"Alejandro Esquivel Álvarez, Elías Quesada Morales, María Paz Villegas Calero, Daniela Matarrita Brenes, M. F. Rojas Salas, German Madrigal Redondo, Marianela Chavarría Rojas, Eleaneth Baltodano Viales","doi":"10.24018/ejbio.2022.3.2.332","DOIUrl":null,"url":null,"abstract":"The CRISPR-Cas system discovered in the eighties consists of a series of RNA proteins that signal and messengers of the immune system in prokaryotic organisms to protect against invading antigens of various sources. After the CRISPR-Cas discovery, many research advances were made in the following decades regarding knowledge, techniques, and applications. This showed the system could edit the DNA in an exact and specific manner, which made it very promising to exploit it in various fields, such as the therapeutic field. New therapies of various diseases, industrial applications, food manufacturing, among others, make its impact quite relevant. The following review will focus on the fundamental understanding and implications of CRISPR-Cas techniques has with an ethical and legal view. In addition, to explore some of the applications present and future in the healthcare department, some methods of drug delivery in gene therapy, and new research that is being developed with the CRISPR-Cas technology.","PeriodicalId":72969,"journal":{"name":"European journal of biology and biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of biology and biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24018/ejbio.2022.3.2.332","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The CRISPR-Cas system discovered in the eighties consists of a series of RNA proteins that signal and messengers of the immune system in prokaryotic organisms to protect against invading antigens of various sources. After the CRISPR-Cas discovery, many research advances were made in the following decades regarding knowledge, techniques, and applications. This showed the system could edit the DNA in an exact and specific manner, which made it very promising to exploit it in various fields, such as the therapeutic field. New therapies of various diseases, industrial applications, food manufacturing, among others, make its impact quite relevant. The following review will focus on the fundamental understanding and implications of CRISPR-Cas techniques has with an ethical and legal view. In addition, to explore some of the applications present and future in the healthcare department, some methods of drug delivery in gene therapy, and new research that is being developed with the CRISPR-Cas technology.
CRISPR-Cas技术,未来的工具
80年代发现的CRISPR-Cas系统由一系列RNA蛋白质组成,这些蛋白质是原核生物免疫系统的信号和信使,以抵御各种来源的入侵抗原。CRISPR-Cas发现后,在接下来的几十年里,在知识、技术和应用方面取得了许多研究进展。这表明该系统可以以精确和特定的方式编辑DNA,这使得它在各个领域的开发非常有希望,例如治疗领域。各种疾病的新疗法、工业应用、食品制造等都使其影响非常相关。以下综述将从伦理和法律角度重点介绍CRISPR-Cas技术的基本理解和影响。此外,探索目前和未来在医疗保健部门的一些应用,基因治疗中的一些药物递送方法,以及CRISPR-Cas技术正在开发的新研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信